Cancer cells' genetic pathways show which patients are likely to develop aggressive types of the disease

Sept. 7, 2016 -- Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk. The new findings could help physicians prescribe the most effective treatments for each patient based on how genes are activated in the individual tumor.

These findings raise the possibility that by determining the gene expression profile of a patient's tumor, physicians may be able to identify aggressive disease at the outset of diagnosis and start treatment earlier," said Sungyong You, PhD, an instructor in the Cedars-Sinai Department of Surgery and the first author of the study.

Sunyong You, PhD
Sunyong You, PhD uses computational, laboratory and genomics methods to learn more about the molecular mechanisms that promote lethal prostate cancer.

...continue reading "New tumor analysis method identifies high-risk prostate cancer"